Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 7/10/20 → 11/30/22 |
Financiación
- Avanir Pharmaceuticals: 30.497,00 US$
7-AVP-786-205: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (deudextromethorphan hydrobromide [d6- DM]/quinidine sulfate [Q]) for the Treatment of Neurobehavioral Di
- Lee, Daniel (PI)